Core Insights - Elanco Animal Health Incorporated reported revenue of $1.19 billion for the quarter ended March 2025, reflecting a year-over-year decline of 1% [1] - The earnings per share (EPS) for the same period was $0.37, an increase from $0.34 a year ago, indicating a positive trend in profitability [1] - The reported revenue exceeded the Zacks Consensus Estimate of $1.17 billion, resulting in a surprise of +2.17% [1] - The company delivered an EPS surprise of +19.35%, with the consensus EPS estimate being $0.31 [1] Revenue Breakdown - Total Pet Health revenue was $635 million, slightly below the estimated $649.71 million, representing a -0.6% change year-over-year [4] - Total Contract Manufacturing revenue reached $12 million, surpassing the estimated $9.95 million, marking a +20% change compared to the previous year [4] - Total Farm Animal revenue was $546 million, exceeding the estimated $510.15 million, but showing a -1.8% change year-over-year [4] Stock Performance - Elanco Animal Health shares have returned +14.2% over the past month, outperforming the Zacks S&P 500 composite's +10.6% change [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]